Document is current
Any future updates will be listed below
-
Authors
Lobaina, Yadira
Chen, Rong
Suzarte, Edith
Ai, Panchao
Huerta, Vivian
Tan, Changyuan
Alvarez-Lajonchere, Liz
Liling, Yang
Musacchio, Alexis
Silva, Ricardo
Guillén, Gerardo
Zaixue, Jiang
Yang, Ke
Perera, Yasser
Hermida, Lisset https://orcid.org/0000-0001-8470-183X
-
Funding
Funding for this research was provided by:
National key R&D program of China (2021YFE0192200)
Hunan Provincial Base for Scientific and Technological Innovation Cooperation (2019CB1012)
The Science and Technology Innovation Program of Hunan Province (2020RC5035)
Hunan Provincial Innovative Construction Program (2020WK2031)
- License Information
-
More Information
Article History
Received: 26 October 2022
Accepted: 5 March 2023
First Online: 23 June 2023
Declarations
:
: The authors declare that there are no conflicts of interest.
: The animal study was approved by the Institutional Animal Care and Use Committee of Beijing Vital River Laboratory Animal Technology Co., Ltd. The standards of the laboratory animal room complied with the national standards of the People's Republic of China GB14925-2010. The human sera from COVID-19 convalescent and negative individuals were collected at The Eighth and Ninth People’s Hospital of the city of Dongguan (Guangdong Province, China). The study protocol was approved by the institutional ethics committees of both hospitals and was carried out in accordance with the principles of the Helsinki declaration.
